Overview

Virtual Conference Schedule
March 22: 8:30-10:00AM, 1:30-3:00PM
March 23: 1:00-4:30PM

This event will take place in Eastern Standard Time

In March 2016, DIA will be virtually broadcasting four sessions to a remote audience from our Medical Affairs and Scientific Communications 2016 Annual Forum. Those that are unable to join us in person will now have the opportunity to participate right from the comfort of their office. Through an online platform, guests will be able to participate in chat forums with fellow online registrants, view the four conference sessions in real time, submit questions for the speakers, and live tweet the event. View more details about the virtual conference on the agenda tab.

Click here for more details about the Medical Affairs and Scientific Communications 2016 Annual Forum.

As a condition of registering for the DIA event, you acknowledge DIA’s right to record and stream, by any audio, video, or audio-visual means, the DIA event and your participation in the event, including your image, questions, and comments. You further acknowledge DIA’s right, as the sole and exclusive owner of the event, to use, reproduce, publish, license, sell, display, and distribute copies of the event in any print or electronic medium (such as CD-ROM or via the Internet) consistent with DIA’s nonprofit and tax exempt purposes. You agree to waive any right to royalties or compensation for any of the rights you have granted DIA.

Who should attend?

Medical Communications
Medical Writing
Medical Liaisons
Medical Information
Medical Call Center Environment
Regulatory Affairs
Clinical Research
Professional Education, Training, and Development
Document Management/eSubmissions

Learning objectives

At the conclusion of this virtual conference, participants should be able to:

Policy and Medicine

Describe and discuss current policy regulating communications
Explore the trends and directions of these and other activities in order to better prepare and react to changes as they evolve

Demonstrating and Communicating the Value of Medicines Through Health Economic and Outcomes Evidence

Review the external regulatory and health care landscape
Describe the scope of health pharmacoeconomic research and the differences from clinical trials
Discuss why health outcomes and pharmacoeconomics data are important to payer customers and how they use this information
Examine effective medical communication techniques and tools utilized by field medical colleagues

Making Patients the Priority

Discuss the patient’s perspective, the top concerns and needs upon diagnosis of a chronic disease
Explain how advocacy and support groups are a vital part of helping awareness as well as healing and connection to solutions for patients and caregivers
Discuss new ways to use our communications knowledge and platforms to identify some new solutions in which patients want or need from pharmaceutical companies
Recall how patients have benefited from partnering with industry programs/offerings, the limitations and gaps that still exist, and possible opportunities in the future
Describe how the evolution of customer surveys and feedback have been adapted to offer value to patients including quality of answers, evolving response documents, improved time to therapies, and access to other resources for patient therapy

New Drugs of 2015 Review

Identify the indications and routes of administration of the new therapeutic agents
Describe the important pharmacokinetic properties and the unique characteristics of the new drugs
Restate the most important adverse events and precautions of the new drugs
Compare the new drugs to the older therapeutic agents to which they are most similar in activity
Assess information regarding the new drugs that should be communicated to patients

Have an account?

Medical Affairs and Scientific Communications 2016 Annual Forum Virtual Conference

Overview

Who should attend?

Learning objectives

Be informed and stay engaged.